IP Library Granted Patent US 12673039
Granted Patent B2
US 12673039 · App. 17/428,600 · Granted Jul 7, 2026

Methods of inducing autophagy using coumarin derivatives and related compounds

Inventors: Gordon J. Lithgow (Novato, CA); Julie K. Andersen (Novato, CA); Shankar J. Chinta (Novato, CA); Manish Chamoli (San Mateo, CA)
Assignee: Buck Institute for Research on Aging
A61K31/37A61K31/4745A61K31/5377A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12673039
App. No.
17/428,600
Granted
Jul 7, 2026
Kind
B2
Abstract

In various embodiments compounds that induce and/or promote autophagy are provided as wells as methods of use thereof (e.g., in the prophylaxis or treatment of chronic pathologies associated with aging). In one illustrative, but non-limiting embodiments the compound(s) comprise, inter alia, coumarin 106.

Claims (4)

1 . A method of promoting autophagy in cells, said method comprising:

contacting said cells with an effective amount of one or more compounds that promote autophagy, where said compounds are selected from the group consisting of 2,3,6,7,10,11-Hexahydro-1H,5H-cyclopenta(3,4)(1)benzopyrano(6,7,8-ij)quinolizin-12(9H)-one (Coumarin 106; CAS Registry No. 41175-45-5, also known as AIC106),

or a pharmaceutically acceptable salt thereof.

2 . The method of claim 1 , wherein the cells are in vivo in a mammal and the method comprises administering said compounds to said mammal.